TRVI
Trevi Therapeutics, Inc. · Healthcare
Director Mette Kirstine Agger bought $3.8M of Trevi Therapeutics, Inc.
Bought$3,750,000
$10.00Price
375,000Shares
+48%Stake
What TRVI did for a copier
Prices for TRVI after this filing aren't in yet.
Mette Kirstine Agger's record
2 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, May 9. Filed Mon, May 13, 1:01 PM ET, during the session. Not investment advice.